Design Therapeutics Cash Flow Statement 2020-2023 | DSGN

Fifteen years of historical annual cash flow statements for Design Therapeutics (DSGN).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020
$-66.86$-63.31$-35.53$-8.28
$-5.55$-0.99$0.05$-0.07
$13.12$10.99$4.71$0.48
$7.57$10.00$4.76$0.41
$0$0$0$0
$0$0$0$0
$0$0$0$0
$1.97$-3.39$-1.02$-0.40
$0.73$1.99$1.40$-0.81
$-58.56$-51.32$-29.38$-8.67
$-0.26$-0.88$-1.54$-0.08
$0$0$0$0
$0$0$0$0
$52.79$-220.11$-52.11$-33.49
$0$0$0$0
$52.79$-220.11$-52.11$-33.49
$0$0$0$0
$52.54$-220.99$-53.64$-33.56
$0$0$0$0
$0$0$0$-0.20
$0$0$0$-0.20
$0.72$0.66$254$0.00
$0.72$0.66$379$44.73
$0$0$0$0
$0$-0.43$0$0
$0.72$0.24$379$44.53
$-5.30$-272.07$296$2.30
$13.09$10.93$4.69$0.45
$0$0$0$0